Among patients with OSA, the risk for severe COVID-19 does not differ among those who are adherent vs nonadherent to CPAP.
Resmed Inc (RMD) announced an update on their ongoing clinical study. ResMed’s new study, “Trial of a New Software Tool for Personalized Minimum and Maximum Pressure Recommendations in New CPAP Users ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results